WeightWatchers files for bankruptcy protection as weight-loss drugs dominate – National

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

WeightWatchers files for bankruptcy protection as weight-loss drugs dominate – National

Popular weight-loss drugs like Ozempic and Wegovy are helping millions worldwide shed unwanted pounds, but it appears they’ve also been eating away at WeightWatcher’s profits.

WW International, formerly known as WeightWatchers, filed for Chapter 11 bankruptcy protection on Tuesday in a bid to protect itself and cut debt after hugely popular obesity drugs capsized its once successful business model.

It hopes to eliminate debts of more than US$1.1 billion while positioning the “company for long-term growth and success.” The type of bankruptcy allows the company to continue operating while it restructures its assets and fights to continue operating.

The company has accumulated substantial debt of around $1.6 billion.

Story continues below advertisement

WeightWatchers said it will remain “fully operational” during the process with

This is the hidden content, please

• Sign In
• or
• Sign Up

WeightWatchers formed more than 60 years ago, starting out by offering weekly weight-loss support group meetings. The first meeting, which cost New Yorkers $2 to attend, attracted 400 people looking to lose weight.

A year later, the company began to offer a franchise option and, soon after, WeightWatchers transformed into a household name with millions of members around the globe.

0:26
Weight Watchers drops ‘weight’ from its name

The rising combination of fitness influencers and popularity of GLP-1 drugs, such as Novo Nordisk’s Ozempic and Wegovy, are now a major threat to traditional weight-loss programs.

This is the hidden content, please

• Sign In
• or
• Sign Up

/applications/core/interface/js/spacer.png">

Get weekly health news

Receive the latest medical news and health information delivered to you every Sunday.

During Tuesday’s first quarter results, WW International revealed that subscribers were down more than 14 per cent compared to the same ******* last year, at 3.4 million. Revenues of nearly $187 million plunged almost 10 per cent compared with the year prior.

Story continues below advertisement

The company is due to be taken over by a group of investors, while shareholders will retain a nine per cent stake once the process is complete in 45 days, per the filing.

Shares of the company, which once boasted Oprah Winfrey as one of its top shareholders and a member of the board of directors, have traded at under $1 since early February.

In after-hours trading on Tuesday, the stock plunged by half, to 39 cents.

This is the hidden content, please

• Sign In
• or
• Sign Up

/applications/core/interface/js/spacer.png">

1:54
GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes

Previous Video

Next Video

Trending Now

• This is the hidden content, please

  • Sign In
  • or
  • Sign Up

  /applications/core/interface/js/spacer.png">

  ********* government ‘fact check’ dismisses Trump administration claims about border

• This is the hidden content, please

  • Sign In
  • or
  • Sign Up

  /applications/core/interface/js/spacer.png">

  RCMP have ‘scaled back’ search for missing N.S. children, say little chance they are alive

Winfrey left the WW board of directors in February 2024 after she told People magazine that she had been taking weight-loss drugs, the company said at the time.

Winfrey, the company’s largest individual shareholder at the time, pledged to donate her stake to the National Museum of African American History and Culture in Washington, D.C.

Story continues below advertisement

FILE – Oprah Winfrey announced her exit from the WeightWatchers board of directors on Feb. 28, 2024.

John Salangsang/Golden Globes 2024/Golden Globes 2024 via Getty Images

In 2023, the company moved into the prescription drug weight loss business — particularly with the $106 million acquisition of Sequence, now WeightWatchers Clinic, a telehealth service that helps users get prescriptions for drugs like Ozempic, Wegovy and Trulicity.

Its latest earnings report Tuesday shared that its clinical subscription revenue — or weight-loss medications — jumped 57 per cent year-over-year to $29.5 million.

The company has estimated assets and liabilities in the range of $1 billion to $10 billion, according to the petition filed in Delaware bankruptcy court.

— With files from The Associated Press

More on Health
More videos

&copy 2025 Global News, a division of Corus Entertainment Inc.

This is the hidden content, please

• Sign In
• or
• Sign Up

#WeightWatchers #files #bankruptcy #protection #weightloss #drugs #dominate #National

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up